Stay updated on Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page.

Latest updates to the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision, v3.4.2, has been added. The prior funding-lapse notice and the v3.4.1 revision have been removed.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a Notice about a lapse in government funding and updated the site Revision to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe history page adds a glossary display and color-coded highlights for additions and deletions, plus a revision note (v3.4.0); older notes (No FEAR Act data and Revision: v3.3.4) were removed.SummaryDifference0.6%

- Check42 days agoChange DetectedA new revision entry 'Revision: v3.3.4' was added to the study history, replacing the previous 'Revision: v3.3.3', and there are no changes to study data or descriptions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedThe footer revision label on the Record History page updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab in Pediatric FH: Efficacy and Safety Clinical Trial page.